ReviewNature reviews. Neurology2024

Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.

Suzanne E Schindler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.